Search
for
Sort by
Research 31–60 of 1000+
- Evaluation of Efficacy of Platelet rich Plasma on Androgenetic Alopecia: A Multimodal Assessment Using Trichoscopy, Histopathology, and CD34 Immunohistochemical Assay
- Table 1_Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients.docx
- Supplementary file 1_Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients.docx
- Oral Drug as Effective as Topical Cream for Male Pattern Baldness
- An overview on Herbal Shampoo Formulation And Development
- 69 Risk-benefit appraisal of systemic JAK inhibitors for alopecia areata: a comprehensive meta-analysis assessing safety and adverse effects
- EPH39 Alopecia Areata: Targeted Review of Adverse Events Associated with Clinical Studies of Treatments
- Low-Dose Oral Minoxidil for Alopecia: A Comprehensive Review
- Growing Hair with Botox
- Mesotherapy as a Promising Alternative to Minoxidil for Androgenetic Alopecia: A Systematic Review
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- Management of Chemotherapy-Induced Alopecia With Scalp Cooling
- Platelet-Rich Plasma for the Treatment of Androgenic Alopecia: A Systematic Review
- Complications Post-COVID-19 and Risk Factors among Patients after Six Months of a SARS-CoV-2 Infection: A Population-Based Prospective Cohort Study
- Adverse effects of low-dose oral minoxidil for androgenetic alopecia in 435 patients
- Efficacy of botulinum toxin A injection in the treatment of androgenic alopecia: A Comparative Controlled Study
- Literature Review on Korean Medicine Treatment for Alopecia
- Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study
- ADVERSE EFFECTS OF RITLECITINIB IN ADULTS AND ADOLESCENTS WITH ALOPECIA AREATA: A LITERATURE REVIEW
- Safety Assessment of Ritlecitinib Based on the FDA Adverse Event Reporting System (FAERS) Database: A Real‐World Pharmacovigilance Study
- COMPARISON OF THERAPEUTIC EFFICACY OF MICRONEEDLING WITH PLATELET-RICH PLASMA PLUS 5% MINOXIDIL AND 5% MINOXIDIL ALONE IN ANDROGENETIC ALOPECIA
- Low‐Dose Oral Minoxidil and Associated Adverse Events: Analyses of the FDA Adverse Event Reporting System (FAERS) With a Focus on Pericardial Effusions
- Tolerance and safety profile of sublingual minoxidil in the treatment of androgenic alopecia
- Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia
- Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program
- Chronic Overlapping Pain Conditions and Nociplastic Pain
- Resfriamento de couro cabeludo para prevenção de alopecia induzida por quimioterapia: Estudo descritivo
- Efficacy and safety of oral alitretinoin in chronic hand eczema and palmoplantar pustulosis
- Acne fulminans: explosive systemic form of acne
- 3212 Isolated basilar artery reversible cerebral vasoconstriction syndrome associated with finasteride and vaping